AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet AMPH Quote Amphastar P

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 66 72 66
ShortTermInvest 0 1 3
Cash 66 73 68
AccountReceivab 33 27 36
Inventories 71 80 64
DeferredIncomeT 0 0 0
OtherCurrentAss 2 1 10
TotalCurrentAss 176 184 188
PPE 254 275 319
AccumulatedDepr -112 -122 -133
NetPPE 142 153 185
EquityAndOtherI 0 0 0
Goodwill 0 4 4
IntangibleAsset 40 46 41
OtherLTAssets 5 9 9
TotalNonCurrent 214 244 267
TotalAssets 390 428 455
ShortTermDebt 11 5 6
AccountsPayable 14 16 17
TaxesPayable 3 8 3
AccruedLiabilit 1 1 0
DeferredRevenue 1 0 0
OtherCurrentLia 13 14 16
TotalCurrentLia 60 61 67
Debt 30 32 41
DeferredTaxesLi 0 1 1
DeferredRevenue 2 0 0
OtherLTLiabilit 2 3 8
TotalNonCurrent 35 38 50
TotalLiabilitie 95 98 117
CommonStock 0 0 0
AdditionalPaidI 248 283 314
RetainedEarning 60 71 76
AccumulatedOthe -2 -5 -2
TotalStockholde 296 329 337
TotalLiabilitie 390 428 455
Amphastar Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Amphastar Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.